Business
Cardax Astaxanthin Compound Chosen for Important NIH Anti-Aging Research Program
Cardax Astaxanthin Compound Chosen for Important NIH Anti-Aging Research Program.
About this update from Cardax Inc
[{"type":"text","content":"\n \n Cardax, Inc. (“Cardax”) (OTCQB:CDXI) and the University of Hawaii (“UH”) \n announced today that the National Institute on Aging (“NIA”), one of the \n federal government’s National Institutes of Health (“NIH”), has selected \n Cardax’s proprietary astaxanthin compound CDX-085 for its anti-aging \n Interventions Testing Program (“ITP”). Only 4-5 compounds per year are \n typically chosen by the NIA for this program.\n \n \n This selection resulted from a proposal to the ITP submitted by UH \n faculty Bradley Willcox, M.D. and Richard Allsopp, Ph.D. that was given \n a “high priority” ranking by the NIA. Dr. Willcox is Professor and \n Director of Research at the Department of Geriatric Medicine, John A. \n Burns School of Medicine), University of Hawaii (“JABSOM”), Principal \n Investigator of the NIH-funded Kuakini Hawaii LIFESPAN and HEALTHSPAN \n Studies, and Cardax Scientific Advisory Board member. Dr. Allsopp is an \n Associate Professor at the Institute for Biogenesis Research at JABSOM.\n \n \n Assuming pilot studies to confirm stability in mouse chow and \n bioavailability are successful, the NIA would begin studies with CDX-085 \n in 2018.\n \n \n The ITP, according to Longevity Magazine, is the most rigorous aging \n research program in the U.S. It is funded by the NIA and conducted \n through cooperative agreement grants at the University of Michigan, the \n University of Texas Health Science Center at San Antonio, and Jackson \n Labs. Anti-aging research candidates selected for the NIA program (“ITP \n selectees”) are extensively screened and chosen by NIH for their \n potential impact on lifespan extension and their ability to delay \n disease and dysfunction in mice at different ages. ITP selectees are \n sourced from pharmaceuticals, nutraceuticals, foods, diets, dietary \n supplements, plant extracts, hormones, peptides, amino acids, chelators, \n redox agents, and other agents or mixtures of agents.\n \n \n The ITP testing protocols provide sufficient statistical power to detect \n lifespan changes in the 10–15 percent range. In addition, ITP selectees \n are tested to determine if they have effects on a range of late-life \n traits, potentially including studies of immune function, hormonal an...